Atlas Trials

Bromocriptine for Patients With Schizophrenia and Prediabetes

Clinical trial NCT03575000 · NOT_YET_RECRUITING

Trial details

NCT number
NCT03575000
Sponsor
VA Pittsburgh Healthcare System
Status
NOT_YET_RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
SchizophreniaPreDiabetes
Start date
2026-01-01
Primary completion
2026-07-31
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.